Skip to main content
OpenTrials
Completed

NCT Number: NCT01237691

An Evaluation of California's Experiment With HOPE

The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Sacramento Metro IV Parole Unit.

Sacramento, California, 95811, United States

About this study

The California HOPE pilot program is being implemented under the authority granted in Penal Code 5058.1. The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group compared with parole-as-usual.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Assigned to the Sacramento Metro IV Parole Unit.
  • Released from a term of return-to-custody for a violation for, or involving, the use of drugs.
  • Have a maximum controlling discharge date at least one year from the date of release from the return-to-custody term.

Exclusion criteria

  • History of convictions for crimes that require registration under Penal Code Section 290.

Treatment and study plan

HOPE supervision

Behavioral

HOPE entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). HOPE includes regular random drug testing.

Other names: HOPE, COPE

Parole-as-usual

Behavioral

Parolees are supervised under standard parole supervision practice in California.

Other names: Routine parole

Primary outcomes

  1. Days incarcerated

    Time frame: 24 months

    Total number of days incarcerated in jail or prison

Secondary outcomes

  1. % positive drug tests

    Time frame: 24 months

    Percentage of random and scheduled drug tests that test positive for illicit drugs

  2. %Missed

    Time frame: 24 months

    Percentage of parole appointments that are missed.

  3. Revocation rate

    Time frame: 24 months

    Percentage of parolees that are revoked from probation and returned to prison for either a technical violation or on a new charge.

  4. New arrests

    Time frame: 24 months

    Number of new arrests.

  5. Perceptions of risk of detection

    Time frame: 24 months

    Parolees perceived risk of detection for drug use

Sponsors and collaborators

Lead sponsor

Pepperdine University

Other

Collaborators

  • University of California, Irvine
  • University of California, Los Angeles

Registry information

Official study title

Phase 1 Study of California's HOPE Experiment

Important dates

Study start
2010
Primary completion
2012
Study completion
2013
First posted
Nov 9, 2010
Registry last updated
Apr 10, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.